These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2736747)

  • 1. Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3.
    van der Kraaij AM; van Eijk HG; Koster JF
    Circulation; 1989 Jul; 80(1):158-64. PubMed ID: 2736747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine.
    van der Kraaij AM; Mostert LJ; van Eijk HG; Koster JF
    Circulation; 1988 Aug; 78(2):442-9. PubMed ID: 3396180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
    Katoh S; Toyama J; Kodama I; Kamiya K; Akita T; Abe T
    Eur Surg Res; 1992; 24(6):349-55. PubMed ID: 1338045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
    Ambrosio G; Zweier JL; Jacobus WE; Weisfeldt ML; Flaherty JT
    Circulation; 1987 Oct; 76(4):906-15. PubMed ID: 2820615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant.
    Rao PS; Liu XK; Das DK; Weinstein GS; Tyras DH
    Ann Thorac Surg; 1991 Oct; 52(4):908-12. PubMed ID: 1929656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation.
    Reznick AZ; Kagan VE; Ramsey R; Tsuchiya M; Khwaja S; Serbinova EA; Packer L
    Arch Biochem Biophys; 1992 Aug; 296(2):394-401. PubMed ID: 1321584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iron overload in the isolated ischemic and reperfused rat heart.
    Pucheu S; Coudray C; Tresallet N; Favier A; de Leiris J
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):701-11. PubMed ID: 8241014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-mediated cardiotoxicity develops independently of extracellular hydroxyl radicals in isolated rat hearts.
    Watts JA; Ford MD; Leonova E
    J Toxicol Clin Toxicol; 1999; 37(1):19-28. PubMed ID: 10078156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    Du Toit EF; Muller CA; McCarthy J; Opie LH
    J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective and antioxidant effects of apomorphine.
    Khaliulin I; Borman JB; Chevion M; Schwalb H
    Free Radic Res; 2003 Jul; 37(7):721-30. PubMed ID: 12911268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
    Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyrroline derivative of mexiletine offers marked protection against ischemia/reperfusion-induced myocardial contractile dysfunction.
    Li H; Xu KY; Zhou L; Kalai T; Zweier JL; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2000 Nov; 295(2):563-71. PubMed ID: 11046089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.
    Sargent CA; Wilde MW; Dzwonczyk S; Tuttle JG; Murray HN; Atwal K; Grover GJ
    Cardiovasc Res; 1996 Feb; 31(2):270-7. PubMed ID: 8730404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of iron on membrane phospholipid breakdown in ischemic-reperfused rat heart.
    Liu XK; Prasad MR; Engelman RM; Jones RM; Das DK
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1101-7. PubMed ID: 2221118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
    Kramer JH; Weglicki WB
    Free Radic Biol Med; 1996; 21(6):813-25. PubMed ID: 8902527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant and lysosomotropic properties of acute D-propranolol underlies its cardioprotection of postischemic hearts from moderate iron-overloaded rats.
    Kramer JH; Murthi SB; Wise RM; Mak IT; Weglicki WB
    Exp Biol Med (Maywood); 2006 Apr; 231(4):473-84. PubMed ID: 16565443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts.
    Doppelfeld IS; Parnham MJ
    Methods Find Exp Clin Pharmacol; 1992; 14(6):419-30. PubMed ID: 1469951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
    Ikizler M; Erkasap N; Dernek S; Kural T; Kaygisiz Z
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):404-10. PubMed ID: 18065337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-hydroxy-pyrroline modification of verapamil exhibits antioxidant protection of the heart against ischemia/reperfusion-induced cardiac dysfunction without compromising its calcium antagonistic activity.
    Mandal R; Kutala VK; Khan M; Mohan IK; Varadharaj S; Sridhar A; Carnes CA; Kálai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2007 Oct; 323(1):119-27. PubMed ID: 17646427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.